Celebrate World Retina Day at the 2024 EURETINA Congress

News
Article

As part of the Barcelona meeting, retina specialists can recognise the awareness day early

The Earth with the EURETINA logo superimposed on top. Image credit: ©dimazel – stock.adobe.com and EURETINA

Many of the World Retina Day symposia are presented in partnership with other national or global retina societies. Image credit: ©dimazel – stock.adobe.com and EURETINA

This year, the European Society of Retina Specialists (EURETINA) will host a full suite of special programming to recognise World Retina Day. Typically, World Retina Day is observed on the last Saturday or Sunday of September (subject to local time zones). For the European clinicians attending EURETINA, that means the special day falls on 28 September, but EURETINA leadership is starting the festivities a full week early.

On 21 September, congress attendees can choose from 16 different events specially designed to recognise World Retina Day. Many of these are presented in partnership with other national or global retina societies. Topics range from diabetic retinopathy management programmes to ocular traumas to cutting-edge innovations in the surgical space.

These are the special EURETINA symposia being hosted on Saturday, 21 September in honour of World Retina Day. Register for the sessions here.

Asia-Pacific Vitreo-retina Society (APVRS): Consensus Statements on Polypoidal Choroidal Vasculopathy

9:00-10:00 CEST

Chaired by Paisan Ruamviboonsuk (Thailand) and Timothy Lai (Hong Kong)

European Association for Diabetic Eye Complications (EAsDEC) & Imaging Section: Diabetic Eye Disease – where are we now? Are we addressing the concerns of our society and our patients?

9:00-10:00 CEST

Chaired by Tunde Peto (UK) and Ali Erginay (France)

Club Jules Gonin Symposium

9:00-10:00 CEST

Chaired by José García Arumí (Spain) and Thomas Wolfensberger (Switzerland)

Retina World Congress (RWC): Innovations in Retina

9:00-10:00 CEST

Chaired by Kourous Rezaei and Baruch Kuppermann (US)

Brazilian Retina & Vitreous Society—Diabetic Retinopathy: Are our cases the same as yours?

11:30-12:30 CEST

Chaired by Arnaldo Bordon, Osias Francisco Souza and Silvana Vianello (Brazil)

R.E.T.I.N.A.: Understanding and Advancing Research Methodology for Retinal Specialists

11:30-12:30 CEST

Chaired by David Steel (UK) and Varun Chaudhary (Canada)

Sociedad Española de Retina y Vitreo (SERV): Current concepts in diabetic retinopathy

11:30-12:30 CEST

Chaired by Luis Arias Barquet and Alfredo Garcia Layana (Spain)

Ukrainian Society: Ocular Trauma

11:30-12:30 CEST

Chaired by Nadiia Ulianova (Ukraine) and Camiel J.F. Boon (Netherlands)

FLORETINA: Clinical insights and surgical tips in the management of lamellar macular holes

15:30-16:30 CEST

Chaired by Mario R Romano and Stanislao Rizzo (Italy)

German Retina Society

15:30-16:30 CEST

Chaired by Nicole Eter (Germany), Horst Helbig (Germany) and Nicolas Feltgen (Switzerland)

International Society for Al in Ophthalmology, EAO & EVER - Al and Retina: Key issues in 202415:30-16:30 CEST

Chaired by Andrzej Grzybowski (Poland) and Tunde Peto (UK)

Taiwan Retinal Society- Interconnected Health: Unlocking Insights through Ocular & Systemic Biomarkers

15:30-16:30 CEST

Chaired by Shwu-Jiuan Sheu, Cheng-Kuo Cheng and San-Ni Chen (Taiwan)

Japanese Retina & Vitreous Society - Pachychoroid/Central serous chorioretinopathy, East & West

16:45-17:45 CEST

Chaired by Taiji Sakamoto, Kazuaki Kadonosono and Akitaka Tsujikawa (Japan)

American Society of Retina Specialists (ASRS) Cutting Edge Treatments: Updates from the ASRS

16:45-17:45 CEST

Chaired by Carl Awh (US) and Stanislao Rizzo (Italy)

Greek Vitreo-Retinal Society (GVRS): When medical "retina" needs surgical "retina" & vice versa

16:45-17:45 CEST

Chaired by Efstratios Parikakis and Tryfon Rotsos (Greece)

Singapore Society of Ophthalmologists - Establishing a diabetic retinopathy management program: from primary to tertiary care

16:45-17:45 CEST

Chaired by Gavin Tan (Singapore)


Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
Related Content
© 2025 MJH Life Sciences

All rights reserved.